CFGS
ELV icon

Concourse Financial Group Securities’s Elevance Health ELV Stock Holding History

Concourse Financial Group Securities’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-2,393
Closed -$935K – 588
2024
Q4 		$935K Sell
2,393
-153
-6% -$64K 0.05% 342
2024
Q3 		$1.32M Buy
2,546
+1,422
+127% +$760K 0.08% 244
2024
Q2 		$609K Sell
1,124
-84
-7% -$44.4K 0.04% 394
2024
Q1 		$626K Buy
1,208
+122
+11% +$60.7K 0.04% 395
2023
Q4 		$512K Sell
1,086
-380
-26% -$176K 0.04% 433
2023
Q3 		$638K Sell
1,466
-10
-0.7% -$4.54K 0.05% 365
2023
Q2 		$656K Buy
1,476
+54
+4% +$24.9K 0.05% 376
2023
Q1 		$654K Sell
1,422
-191
-12% -$90.9K 0.05% 368
2022
Q4 		$827K Buy
+1,613
New +$819K 0.07% 298
2022
Q3 		– Sell
-1,606
Closed -$768K – 2126
2022
Q2 		$775K Buy
1,606
+133
+9% +$65.8K 0.07% 298
2022
Q1 		$723K Buy
1,473
+137
+10% +$62.6K 0.05% 350
2021
Q4 		$619K Sell
1,336
-189
-12% -$79.5K 0.04% 437
2021
Q3 		$568K Buy
1,525
+180
+13% +$68.4K 0.03% 446
2021
Q2 		$514K Buy
1,345
+138
+11% +$52.7K 0.03% 454
2021
Q1 		$433K Buy
1,207
+80
+7% +$25.7K 0.03% 453
2020
Q4 		$362K Sell
1,127
-399
-26% -$122K 0.03% 448
2020
Q3 		$410K Sell
1,526
-479
-24% -$129K 0.04% 372
2020
Q2 		$527K Buy
2,005
+171
+9% +$45.6K 0.05% 292
2020
Q1 		$416K Buy
+1,834
New +$500K 0.05% 284
2019
Q3 		– Sell
-33
Closed -$9.04K – 1856
2019
Q2 		$9K Sell
33
-1,730
-98% -$473K ﹤0.01% 1519
2019
Q1 		$505K Buy
1,763
+482
+38% +$139K 0.05% 262
2018
Q4 		$336K Buy
1,281
+1,031
+412% +$283K 0.04% 312
2018
Q3 		$69K Buy
+250
New +$64.9K 0.02% 518

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Concourse Financial Group Securities's ELV Position: Q1 2025 in Review

Concourse Financial Group Securities sold out of Elevance Health (ELV) in Q1 2025, closing a stake of 2,393 shares — an estimated $935K sold.

Concourse Financial Group Securities first reported a position in ELV in Q3 2018 and held it in 23 quarters. The position peaked at $1.32M in Q3 2024. 1,661 funds tracked by Wall St. Rank hold ELV as of Q1 2025.

  • Concourse Financial Group Securities reported no remaining Elevance Health position as of Q1 2025 after selling out during the quarter.
  • Concourse Financial Group Securities sold 2,393 Elevance Health shares in Q1 2025, an estimated $935K.
  • Concourse Financial Group Securities first reported a position in Elevance Health in Q3 2018 and held it in 23 quarters.
  • Concourse Financial Group Securities's Elevance Health position peaked at $1.32M in Q3 2024.
  • 1,661 funds tracked by Wall St. Rank held Elevance Health as of Q1 2025.

Based on Concourse Financial Group Securities's 13F filing for Q1 2025.